Product Images Adenosine

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Adenosine NDC 51662-1643 by Hf Acquisition Co Llc, Dba Healthfirst, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Table 1 - 51662 1643 Table 1

Table 1 - 51662 1643 Table 1

This text provides information on the Strength of a medication supplied in different unit sizes and dosages. Each unit contains 12 mg per 4 mL in a plastic prefilled syringe. It comes in various packaging options: syringe, pouch, or case of 10 syringes. The concentration is 3 mg per mL.*

structure - 51662 1643 structure

structure - 51662 1643 structure

RFID Label - 51662 1643 1 syringe

RFID Label - 51662 1643 1 syringe

This text contains a product code, manufacturing location details, and distribution information. It seems to be related to a certain product's packaging or label.*

Pouch label - 51662 1643 2 pouch

Pouch label - 51662 1643 2 pouch

This is information about Adenosine Injection, USP 12mg per 4mL (3mg per mL) in a 4mL syringe. It is intended for rapid bolus intravenous use and is preservative-free. The medication and fluid path are sterile and non-pyrogenic when the protective cover is undisturbed and the package is intact. Each mL contains Adenosine 3mg and Sodium Chloride 9mg in water for injection. The usual dosage instructions can be found in the package insert. It should be stored at 20°C to 25°C (68°F to 77°F) in a controlled room temperature setting and should not be refrigerated to prevent crystallization. If crystallization occurs, crystals can be dissolved by warming to room temperature. The solution must be clear at the time of use, and any unused portion should be discarded. The container closure does not contain natural rubber latex. The original manufacturer's NDC is 63323-651-96, and it is manufactured by HF Acquisition Co., LLC in Mukilteo, Washington 98275. (Note: Certain characters have been replaced with non-English characters. The actual text may contain proper characters.)*

Case Label - 51662 1643 3 Case label

Case Label - 51662 1643 3 Case label

This is a description of Adenosine Injection, USP 12mg per 4mL syringe used for rapid bolus intravenous use. The medication is preservative-free and sterile. Each mL contains 3mg of Adenosine and 9mg of Sodium Chloride in water for injection. It is important to maintain the integrity of the package to ensure sterility. The syringes may require a needle or blunt. The usual dosage information can be found in the package insert. The storage instructions recommend keeping it at 20 to 25°C (68 to 77°F) and avoiding refrigeration to prevent crystallization. If crystallization occurs, warm the solution to room temperature to dissolve the crystals before use. The closure of the container does not contain natural rubber latex. The product is for rapid bolus intravenous use only and should be used under medical supervision (Rx only). The manufacturer is HFAcquisitionCo., LLC based in Mukilteo, WA 98275.*

RFID Label - 51662 1643 3 rfid

RFID Label - 51662 1643 3 rfid

The product comes with a unique identification number printed on the package. It also mentions to refer to the manufacturer's insert for further details. The item is distributed by HF Acquisitions Co., LLC based in Mukilteo, WA 98275.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.